[1]
F. Fathima, A. Haridas, and B. Lakshmanan, “Docking studies of 3,5-disubstituted thiazolidinedione chalcones as PPAR-γ agonist”, J Pharm Chem, vol. 3, no. 3, pp. 19–23, Jul. 2016, doi: 10.14805/jphchem.2016.art64.